Introduction Semaglutide Has emerged as a groundbreaking medication in the treatment of type 2 diabetes and obesity, with its ability to address multiple health issues through a single solution. Initially developed as a therapy for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonists, a class of drugs that https://johnnyxrkcs.onzeblog.com/31529833/semaglutide-a-breakthrough-in-managing-type-2-diabetes-obesity-and-heart-health